• A cross-linked anti-TNF-alpha aptamer for neutralization of TNF-alpha-induced cutaneous Shwartzman phenomenon: A simple and novel approach for improving aptamers' affinity and efficiency
• A cross-linked anti-TNF-α aptamer for neutralization of TNF-α-induced cutaneous Shwartzman phenomenon: A simple and novel approach for improving aptamers' affinity and efficiency
• A nanoparticle-based approach to improve the outcome of cancer active immunotherapy with lipopolysaccharides
• A patient with acute-onset hemorrhagic necroses and bullae of the legs
• A plausible explanation for male dominance in typhoid ileal perforation
• Brief Report: Endothelial-Specific X-Box Binding Protein 1 Deficiency Limits Tumor Necrosis Factor-Induced Leukocyte Recruitment and Vasculitis
• Contribution of protein Z and protein Z-dependent protease inhibitor in generalized Shwartzman reaction
• Galectin-9 protects mice from the Shwartzman reaction by attracting prostaglandin E2-producing polymorphonuclear leukocytes
• How inflammation modulates central nervous system vessel activation and provides targets for intervention--a personal perspective
• Immune Mechanisms Underlying Susceptibility to Endotoxin Shock in Aged Hosts: Implication in Age-Augmented Generalized Shwartzman Reaction
• Interferon-gamma: a historical perspective
• Protease-activated receptor-4 inhibition protects from multiorgan failure in a murine model of systemic inflammation
• Requirement for Vav proteins in post-recruitment neutrophil cytotoxicity in IgG but not complement C3-dependent injury
• Role of hypercoagulability in steroid-induced femoral head necrosis in rabbits
• The effect of synthetic C-reactive protein on the in vitro immune response of human PBMCs stimulated with bacterial reagents
• Whatever happened to the Shwartzman phenomenon?